Epigenomics AG (EPGNF)
EPGNF Stock Price Chart
Explore Epigenomics AG interactive price chart. Choose custom timeframes to analyze EPGNF price movements and trends.
EPGNF Company Profile
Discover essential business fundamentals and corporate details for Epigenomics AG (EPGNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
31 Dec 2010
Employees
6.00
Website
https://www.epigenomics.comCEO
Noel Thomas Doheny
Description
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.
EPGNF Financial Timeline
Browse a chronological timeline of Epigenomics AG corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Apr 2025
Earnings released on 21 Jan 2025
Earnings released on 30 Sept 2024
Earnings released on 22 Jul 2024
Earnings released on 29 May 2024
Earnings released on 14 Mar 2024
EPS came in at $2.42 , while revenue for the quarter reached $74.91K .
Stock split effective on 8 Dec 2023
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2023
EPS came in at $2.32 , while revenue for the quarter reached $71.85K .
Earnings released on 8 Aug 2023
EPS came in at -$3.37 , while revenue for the quarter reached $76.36K .
Earnings released on 31 May 2023
EPS came in at -$7.12 , while revenue for the quarter reached $145.69K .
Earnings released on 28 Apr 2023
EPS came in at $1.60 , while revenue for the quarter reached $106.64K .
Stock split effective on 27 Dec 2022
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2022
EPS came in at -$0.37 , while revenue for the quarter reached $141.60K .
Earnings released on 10 Aug 2022
EPS came in at -$0.33 , while revenue for the quarter reached $131.80K .
Earnings released on 11 May 2022
EPS came in at -$0.74 , while revenue for the quarter reached $127.20K .
Earnings released on 24 Mar 2022
EPS came in at -$2.53 , while revenue for the quarter reached $205.20K .
Earnings released on 10 Nov 2021
EPS came in at $0.74 , while revenue for the quarter reached $6.73M .
Earnings released on 11 Aug 2021
EPS came in at -$0.99 , while revenue for the quarter reached $138.81K .
Earnings released on 12 May 2021
EPS came in at -$0.96 , while revenue for the quarter reached $124.68K .
Stock split effective on 10 May 2021
Shares were split 1019 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 25 Mar 2021
EPS came in at -$10.52 , while revenue for the quarter reached $369.14K .
Stock split effective on 11 Dec 2020
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Oct 2020
EPS came in at -$2.20 , while revenue for the quarter reached $257.13K .
EPGNF Stock Performance
Access detailed EPGNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.